| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T1 |
0-98 |
Sentence |
denotes |
Recent Clinical and Preclinical Studies of Hydroxychloroquine on RNA Viruses and Chronic Diseases: |
| T2 |
99-118 |
Sentence |
denotes |
A Systematic Review |
| T3 |
120-128 |
Sentence |
denotes |
Abstract |
| T4 |
129-312 |
Sentence |
denotes |
The rapid spread of the new Coronavirus Disease 2019 (COVID-19) has actually become the newest challenge for the healthcare system since, to date, there is not an effective treatment. |
| T5 |
313-398 |
Sentence |
denotes |
Among all drugs tested, Hydroxychloroquine (HCQ) has attracted significant attention. |
| T6 |
399-532 |
Sentence |
denotes |
This systematic review aims to analyze preclinical and clinical studies on HCQ potential use in viral infection and chronic diseases. |
| T7 |
533-719 |
Sentence |
denotes |
A systematic search of Scopus and PubMed databases was performed to identify clinical and preclinical studies on this argument; 2463 papers were identified and 133 studies were included. |
| T8 |
720-915 |
Sentence |
denotes |
Regarding HCQ activity against COVID-19, it was noticed that despite the first data were promising, the latest outcomes highlighted the ineffectiveness of HCQ in the treatment of viral infection. |
| T9 |
916-1060 |
Sentence |
denotes |
Several trials have seen that HCQ administration did not improve severe illness and did not prevent the infection outbreak after virus exposure. |